| Mortality in patients with cancer and coronavirus disease 2019: a systematic review and pooled analysis of 52 studies KS Saini, M Tagliamento, M Lambertini, R McNally, M Romano, M Leone, ... European Journal of Cancer 139, 43-50, 2020 | 347 | 2020 |
| The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients MG Dal Bello, RA Filiberti, A Alama, AM Orengo, M Mussap, S Coco, ... Journal of translational medicine 17, 1-10, 2019 | 142 | 2019 |
| Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective … DJ Pinato, J Tabernero, M Bower, L Scotti, M Patel, E Colomba, S Dolly, ... The Lancet Oncology 22 (12), 1669-1680, 2021 | 112 | 2021 |
| Immunogenicity and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection after coronavirus disease 2019 (COVID-19) vaccination in patients with cancer … A Becerril-Gaitan, BF Vaca-Cartagena, AS Ferrigno, F Mesa-Chavez, ... European journal of cancer 160, 243-260, 2022 | 102 | 2022 |
| Time-dependent COVID-19 mortality in patients with cancer: an updated analysis of the OnCovid registry DJ Pinato, M Patel, L Scotti, E Colomba, S Dolly, A Loizidou, J Chester, ... JAMA oncology 8 (1), 114-122, 2022 | 65 | 2022 |
| Association between response to nivolumab treatment and peripheral blood lymphocyte subsets in patients with non-small cell lung cancer S Ottonello, C Genova, I Cossu, V Fontana, E Rijavec, G Rossi, F Biello, ... Frontiers in immunology 11, 125, 2020 | 65 | 2020 |
| Radiomic detection of EGFR mutations in NSCLC G Rossi, E Barabino, A Fedeli, G Ficarra, S Coco, A Russo, V Adamo, ... Cancer Research 81 (3), 724-731, 2021 | 64 | 2021 |
| Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis F Poggio, M Bruzzone, M Ceppi, B Conte, S Martel, C Maurer, ... ESMO open 3 (4), e000361, 2018 | 64 | 2018 |
| Precision medicine for NSCLC in the era of immunotherapy: new biomarkers to select the most suitable treatment or the most suitable patient G Rossi, A Russo, M Tagliamento, A Tuzi, O Nigro, G Vallome, C Sini, ... Cancers 12 (5), 1125, 2020 | 59 | 2020 |
| Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta … M Tagliamento, E Agostinetto, M Bruzzone, M Ceppi, KS Saini, ... Critical reviews in oncology/hematology 163, 103365, 2021 | 57 | 2021 |
| Outcomes of the SARS-CoV-2 omicron (B. 1.1. 529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre … DJ Pinato, D Ferrante, G Hanbury, M Bower, R Salazar, O Mirallas, ... The Lancet Oncology 23 (7), 865-875, 2022 | 56 | 2022 |
| Update on the management of breast cancer during pregnancy F Poggio, M Tagliamento, C Pirrone, D Soldato, B Conte, C Molinelli, ... Cancers 12 (12), 3616, 2020 | 48 | 2020 |
| Prognostic relevance of circulating tumor cells and circulating cell-free DNA association in metastatic non-small cell lung cancer treated with nivolumab A Alama, S Coco, C Genova, G Rossi, V Fontana, M Tagliamento, ... Journal of Clinical Medicine 8 (7), 1011, 2019 | 46 | 2019 |
| Novel emerging molecular targets in non-small cell lung cancer SE Rebuzzi, L Zullo, G Rossi, M Grassi, V Murianni, M Tagliamento, ... International Journal of Molecular Sciences 22 (5), 2625, 2021 | 44 | 2021 |
| Expected medium-and long-term impact of the COVID-19 outbreak in oncology CE Onesti, M Tagliamento, G Curigliano, N Harbeck, R Bartsch, ... JCO global oncology 5 (1), 162-172, 2021 | 43 | 2021 |
| Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysis F Poggio, L Del Mastro, M Bruzzone, M Ceppi, MG Razeti, P Fregatti, ... Breast Cancer Research and Treatment, 1-7, 2022 | 39 | 2022 |
| VISTA: a promising target for cancer immunotherapy? M Tagliamento, E Agostinetto, R Borea, M Brandão, F Poggio, A Addeo, ... ImmunoTargets and Therapy, 185-200, 2021 | 38 | 2021 |
| Assessing the impact of the COVID-19 outbreak on the attitudes and practice of Italian oncologists toward breast cancer care and related research activities F Poggio, M Tagliamento, M Di Maio, V Martelli, A De Maria, E Barisione, ... JCO Oncology Practice 16 (11), e1304-e1314, 2020 | 38 | 2020 |
| New emerging targets in cancer immunotherapy: the role of VISTA M Tagliamento, P Bironzo, S Novello ESMO open 4, e000683, 2019 | 37 | 2019 |
| Oncological care organisation during COVID-19 outbreak CE Onesti, HS Rugo, D Generali, M Peeters, K Zaman, H Wildiers, ... ESMO open 5 (4), e000853, 2020 | 36 | 2020 |
